Immune Regulation during Chronic Visceral Leishmaniasis

被引:96
作者
Faleiro, Rebecca J. [1 ,2 ]
Kumar, Rajiv [1 ]
Hafner, Louise M. [2 ]
Engwerda, Christian R. [1 ]
机构
[1] QIMR Berghofer, Brisbane, Qld, Australia
[2] Queensland Univ Technol, Brisbane, Qld 4001, Australia
基金
英国医学研究理事会;
关键词
AZAR DERMAL LEISHMANIASIS; TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; SPLENIC MARGINAL ZONE; KINASE-C ACTIVITY; KALA-AZAR; DENDRITIC CELLS; DONOVANI INFECTION; INTERFERON-GAMMA; IFN-GAMMA;
D O I
10.1371/journal.pntd.0002914
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Visceral leishmaniasis is a chronic parasitic disease associated with severe immune dysfunction. Treatment options are limited to relatively toxic drugs, and there is no vaccine for humans available. Hence, there is an urgent need to better understand immune responses following infection with Leishmania species by studying animal models of disease and clinical samples from patients. Here, we review recent discoveries in these areas and highlight shortcomings in our knowledge that need to be addressed if better treatment options are to be developed and effective vaccines designed.
引用
收藏
页数:11
相关论文
共 187 条
[1]
Leishmania-Induced IRAK-1 Inactivation Is Mediated by SHP-1 Interacting with an Evolutionarily Conserved KTIM Motif [J].
Abu-Dayyeh, Issa ;
Shio, Marina Tiemi ;
Sato, Shintaro ;
Akira, Shizuo ;
Cousineau, Benoit ;
Olivier, Martin .
PLOS NEGLECTED TROPICAL DISEASES, 2008, 2 (12)
[2]
Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses [J].
Aichele, P ;
Zinke, J ;
Grode, L ;
Schwendener, RA ;
Kaufmann, SHE ;
Seiler, P .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1148-1155
[3]
Alexander CE, 2001, EUR J IMMUNOL, V31, P1199, DOI 10.1002/1521-4141(200104)31:4<1199::AID-IMMU1199>3.0.CO
[4]
2-6
[5]
The relationship between leishmaniasis and AIDS:: the second 10 years [J].
Alvar, Jorge ;
Aparicio, Pilar ;
Aseffa, Abraham ;
Den Boer, Margriet ;
Canavate, Carmen ;
Dedet, Jean-Pierre ;
Gradoni, Luigi ;
Ter Horst, Rachel ;
Lopez-Velez, Rogelio ;
Moreno, Javier .
CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (02) :334-+
[6]
Leishmaniasis Worldwide and Global Estimates of Its Incidence [J].
Alvar, Jorge ;
Velez, Ivan D. ;
Bern, Caryn ;
Herrero, Merce ;
Desjeux, Philippe ;
Cano, Jorge ;
Jannin, Jean ;
den Boer, Margriet .
PLOS ONE, 2012, 7 (05)
[7]
CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis [J].
Anderson, Charles F. ;
Oukka, Mohammed ;
Kuchroo, Vijay J. ;
Sacks, David .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) :285-297
[8]
IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major Infection [J].
Anderson, Charles F. ;
Stumhofer, Jason S. ;
Hunter, Christopher A. ;
Sacks, David .
JOURNAL OF IMMUNOLOGY, 2009, 183 (07) :4619-4627
[9]
Interferon (IFN)-γ tumor necrosis factor-α, interleukin-6, and IFN-γ receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis [J].
Ansari, Nasim A. ;
Ramesh, Venkatesh ;
Salotra, Poonam .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (07) :958-965
[10]
Elevated levels of interferon-γ, interleukin-10, interleukin-6 during active disease in Indian kala azar [J].
Ansari, Nasim Akhtar ;
Saluja, Sumita ;
Salotra, Poonam .
CLINICAL IMMUNOLOGY, 2006, 119 (03) :339-345